2005Journal of reproductive medicineRequires access

Study on the role of vascular endothelial growth factor in the pathogenesis of ovarian hyperstimulation syndrome

Qide Lin

Open publisher page 0 citations

Abstract

Objective: To explore the role of vascular endothelial growth factor (VEGF) in the pathogenesis of (ovarian) hyperstimulation syndrome (OHSS) in rat model.Methods: There were six rats in each of OHSS group, controlled ovarian hyperstimulation (COH) group and normal control group. The VEGF levels in serum and peritoneal washing fluid were measured by enzyme-labeled immunosorbent assay. Expressions of VEGF protein and mRNA in the ovarian tissue were detected by immunohistochemistry and reverse transcription polymerase chain reaction.Results: The serum VEGF levels in OHSS group, COH group and normal control group were (76.17±18.19) ng/L, (50.68±12.83) ng/L, and (53.68±13.09) ng/L, respectively, and the serum VEGF levels in OHSS group were significantly higher than those in COH group and normal control group ((P0.05,) P0.05 respectively). The peritoneal VEGF level in OHSS group was 17.12 ±1.71 ng/L, which was significantly higher than that in COH group (9.38±5.88) ng/L and normal control group (6.68±1.86) ng/L (P0.05, P0.05 respectively). No significant difference was found between COH group and normal control group. The expression of VEGF protein in ovarian tissue of OHSS group was higher than that of normal control group (P0.05) and COH group (P0.05). But there was no significant difference in (expression) of VEGF protein between COH group and normal control group. The expression of VEGF mRNA in ovarian tissue of OHSS group was higher than that of normal control group and COH group (P0.05, P0.05 respectively). Conclusions: VEGF may play a role in the pathogenesis of OHSS.

About this research paper

What this paper is about

Objective: To explore the role of vascular endothelial growth factor (VEGF) in the pathogenesis of (ovarian) hyperstimulation syndrome (OHSS) in rat model.Methods: There were six rats in each of OHSS group, controlled ovarian hyperstimulation (COH) group and normal control group. The VEGF levels in serum and peritoneal washing fluid were measured by enzyme-labeled immunosorbent assay. Expressions of VEGF protein and mRNA in the ovarian tissue were detected by immunohistochemistry and reverse transcription polymerase chain reaction.Results: The serum VEGF levels in OHSS group, COH group and normal control group were (76.17±18.19) ng/L, (50.68±12.83) ng/L, and (53.68±13.09) ng/L, respectively, and the serum VEGF levels in OHSS group were significantly higher than those in COH group and normal control group ((P0.05,) P0.05 respectively). The peritoneal VEGF level in OHSS group was 17.12 ±1.71 ng/L, which was significantly higher than that in COH group (9.38±5.88) ng/L and normal control group (6.68±1.86) ng/L (P0.05, P0.05 respectively). No significant difference was found between COH group and normal control group. The expression of VEGF protein in ovarian tissue of OHSS group was higher than that of normal control group (P0.05) and COH group (P0.05). But there was no significant difference in (expression) of VEGF protein between COH group and normal control group. The expression of VEGF mRNA in ovarian tissue of OHSS group was higher than that of normal control group and COH group (P0.05, P0.05 respectively). Conclusions: VEGF may play a role in the pathogenesis of OHSS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the role of vascular endothelial growth factor (VEGF) in the pathogenesis of (ovarian) hyperstimulation syndrome (OHSS) in rat model.Methods: There were six rats in each of OHSS group, controlled ovarian hyperstimulation (COH) group and normal control group. The VEGF levels in serum and peritoneal washing fluid were measured by enzyme-labeled immunosorbent assay. Expressions of VEGF protein and mRNA in the ovarian tissue were detected by immunohistochemistry and reverse transcription polymerase chain reaction.Results: The serum VEGF levels in OHSS group, COH group and normal control group were (76.17±18.19) ng/L, (50.68±12.83) ng/L, and (53.68±13.09) ng/L, respectively, and the serum VEGF levels in OHSS group were significantly higher than those in COH group and normal control group ((P0.05,) P0.05 respectively). The peritoneal VEGF level in OHSS group was 17.12 ±1.71 ng/L, which was significantly higher than that in COH group (9.38±5.88) ng/L and normal control group (6.68±1.86) ng/L (P0.05, P0.05 respectively). No significant difference was found between COH group and normal control group. The expression of VEGF protein in ovarian tissue of OHSS group was higher than that of normal control group (P0.05) and COH group (P0.05). But there was no significant difference in (expression) of VEGF protein between COH group and normal control group. The expression of VEGF mRNA in ovarian tissue of OHSS group was higher than that of normal control group and COH group (P0.05, P0.05 respectively). Conclusions: VEGF may play a role in the pathogenesis of OHSS.

Key concepts: Ovarian hyperstimulation syndrome, Vascular endothelial growth factor, Pathogenesis, Endocrinology, Internal medicine, Medicine, Controlled ovarian hyperstimulation, Immunohistochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the role of vascular endothelial growth factor in the pathogenesis of ovarian hyperstimulation syndrome — Research Paper | ScholarLens